However, the second bone marrow biopsy that consisted of more than 20% megakaryoblasts and detection of RBM15::MRTFA(MKL1) fusion by RNA sequencing in the soft tissue lesion has prompted a diagnosis of AML with RBM15::MRTFA(MKL1) fusion. The gene discussed is MRTFA; the disease is acute myeloid leukemia.